Related Topics News -

     
 Title only   |   Print 
     
翰森製藥HS-20093聯合阿得貝利單抗獲納入突破性治療藥物

2026-04-16T  
海通國際:翰森製藥創新產品穩健增長 管線即將進入爆發期

2026-04-02T  
《大行》招銀國際升翰森製藥目標價至46.41元 維持「買入」評級

2026-04-02T  
《大行》交銀國際降翰森製藥目標價至44.5元 去年業績超預期

2026-04-01T  
翰森製藥抽高7% 去年純利增27%獲中銀國際升目標價至43.5元

2026-03-31T  
《藍籌》翰森製藥全年純利55.55億元人民幣升27.1% 派末期息20港仙

2026-03-30T  
《藍籌》翰森製藥全年純利55.55億人民幣增27.1% 末期息派20港仙

2026-03-29T  
翰森製藥創新藥昕越第三項適應症獲藥品註冊證書

2026-03-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.